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We report a tissue diagnostic system which combines two complementary techniques of
time-resolved laser-induced fluorescence spectroscopy TR-LIFS and ultrasonic backscatter
microscopy UBM. TR-LIFS evaluates the biochemical composition of tissue, while UBM
provides tissue microanatomy and enables localization of the region of diagnostic interest. The
TR-LIFS component consists of an optical fiber-based time-domain apparatus including a
spectrometer, gated multichannel plate photomultiplier, and fast digitizer. It records the fluorescence
with high sensitivity nM concentration range and time resolution as low as 300 ps. The UBM
system consists of a transducer, pulser, receiving circuit, and positioning stage. The transducer used
here is 45 MHz, unfocused, with axial and lateral resolutions 38 and 200 m. Validation of the
hybrid system and ultrasonic and spectroscopic data coregistration were conducted both in vitro
tissue phantom and ex vivo atherosclerotic tissue specimens of human aorta. Standard
histopathological analysis of tissue samples was used to validate the UBM-TRLIFS data. Current
results have demonstrated that spatially correlated UBM and TR-LIFS data provide complementary
characterization of both morphology necrotic core and calcium deposits and biochemistry
collagen, elastin, and lipid features of the atherosclerotic plaques at the same location. Thus, a
combination of fluorescence spectroscopy with ultrasound imaging would allow for better
identification of features associated with tissue pathologies. Current design and performance of the
hybrid system suggests potential applications in clinical diagnosis of atherosclerotic plaque. © 2009
American Institute of Physics. DOI: 10.1063/1.3142478
I. INTRODUCTION
Current techniques used for intraluminal investigations
of atherosclerotic plaque include angiography, intravascular
ultrasound IVUS, optical coherence tomography, intravas-
cular magnetic resonance imaging, and optical spectroscopy
near infrared, Raman, etc.. Each of these techniques has
intrinsic advantages and is sensitive to either plaque structure
or composition. However, none of these techniques alone can
provide complete information concerning various markers
involved in plaque vulnerability and rupture which may en-
compass both structure and composition e.g., a thin fibrous
cap, a large lipid-rich pool, increased macrophage activity,
and outward remodeling.1 Thus, new diagnostic techniques
with the capability to concurrently localize and identify ana-
tomic features to characterize the composition of high-risk
plaques are needed in order to reduce the incidence of acute
cardiovascular syndromes and sudden death.
Optical fluorescence spectroscopy techniques have been
reported capable of detecting elastin, collagen, lipids, and
other label-free compositional markers which allow for dif-
ferentiation between normal and diseased arterial tissue.2,3
For example, early studies have shown that fluorescence
techniques, including time-resolved methods, enable detec-
tion of the thin cap fibroatheromas,4 lipid-rich lesions, as
well as fibrotic caps with macrophage and inflammatory cell
infiltration.5–10 However, the poor penetration depth, which
is on the order of hundreds of microns, limits the application
of optical fluorescence spectroscopy. An imaging technique
which can “see through” the tissue is needed to provide
structural information and to improve the overall diagnostic
ability of optical techniques.
Conventional IVUS, which has been used clinically for
assessing vessel wall anatomy since the early 1990s, can
identify luminal diameter, wall thickness, plaque morphol-
aAuthor to whom correspondence should be addressed. Electronic mail:
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ogy, and can assess vessel remodeling.11,12 The advantage of
IVUS includes the use of higher frequencies 20 MHz,
which improves the spatial resolution and achieves penetra-
tion depths of several millimeters, allowing the delineation
of the layered structures in the vessel wall. However, IVUS
is sensitive to fibrous and calcified plaque but not to soft or
lipid-rich plaque.1 To improve the identification of a lipid-
rich plaque and enhance the role of IVUS in vulnerable-
plaque detection, integrated backscatter, assessment of the
radio frequency RF envelope, and spectral analysis of the
RF signal from the plaque have been developed.13–17 Overall,
IVUS can provide great structural information, but lacks the
sensitivity and accuracy to detect biochemical properties as-
sociated with rupture-prone plaques.
Taking into account the requirements of atheroma detec-
tion and evaluation, it is obvious that a combined approach
capable of evaluating structural characteristics as well as bio-
chemical properties of the plaque may provide higher predic-
tive information regarding plaque vulnerability than a single
approach.1,18,19 For example, researchers have demonstrated
in an ex vivo study, that the combination of Raman spectros-
copy and IVUS provides complementary information about
the amount and location of calcified deposits and lipid pools
in atherosclerotic plaques.20
In this context, we report here the conceptual design and
validation of a novel tissue diagnostic system for the charac-
terization and diagnosis of tissues including atherosclerotic
plaques, which combines two complementary techniques:
time-resolved laser-induced fluorescence spectroscopy TR-
LIFS and ultrasonic backscatter microscopy UBM. Based
on the study of this system, it is feasible to further translate
this technique into an intravascular device with a combined
TR-LIFS/IVUS catheter. Such a combination could be useful
for intravascular clinical diagnosis of vulnerable plaque and
may allow researchers or physicians to monitor the effects of
various medical or therapeutic interventions.
II. SYSTEM CONFIGURATION AND
CHARACTERIZATION
We have developed and validated the concept of the
dual-modal system by integrating a TR-LIFS device devel-
oped earlier by our research group21 with a UBM system22
into a compact experimental apparatus and have tested it for
the localization and characterization of human aortic athero-
sclerotic plaque. The conceptual schematic diagram of the
hybrid prototype is given in Fig. 1. The combined system
consisted of four primary modules including the TR-LIFS
and UBM subsystem, the hybrid probe and the control unit.
In the following, we describe the electronic components, the
interface connection and performance of the TR-LIFS and
UBM subsystem, the hybrid probe combining an optical fiber
and high-frequency ultrasonic transducer, and the integration
of the two individual subsystems into one single functional
unit.
A. TR-LIFS components
The electronics and interface connection of the TR-LIFS
subsystem are demonstrated in Fig. 2. The time-dependent
fluorescence intensity decay was acquired through a pulse
sampling method which uses a digitizer and fast-gated detec-
tion to sample the curve repetitively at shorter time intervals
than the sample’s fluorescence lifetime. The excitation light
pulses from a nitrogen laser source MNL205-C, LTB Laser-
technik Berlin, Berlin, Germany at 337.1 nm were directed
into an optical fiber with different configurations bifurcated
or single optical fiber. Laser excitation output can be up to
80 J /pulse and the measured energy at the tip of the fiber
was adjusted to be 2 J /pulse. Following sample excitation,
the emitted fluorescence light was dispersed by the spec-
trometer MicroHR, Horiba Jobin Yvon, Edison, NJ for
time-resolved measurements at discrete steps across the
emission spectrum. The output light was detected by a gated
multichannel plate photomultiplier tube PMT R5916U-50,
Hamamatsu, Bridgewater, NJ, amplified by a wideband pre-
amplifier C-5594–12, 1.5 GHz bandwidth, Hamamatsu,
Bridgewater, NJ, digitized by a fast digital oscilloscope
DPO 7254, 2.5 GHz bandwidth, 20G samples/s, Tektronix,
Richardson, TX, and transferred to the computer. A delay
generator DG535, Stanford research systems, Sunnyvale,
CA was used as the master trigger source to synchronize
the PMT and laser such that the fluorescence decay fell
within the region of the PMT gate. A low jitter
200 ps optical trigger signal was used to trigger the data
acquisition on the oscilloscope. Spectral intensity calibration
was performed with a tungsten-halogen calibration lamp



















FIG. 1. Schematic diagram of the combined TR-LIFS/UBM system. The
combined system consisted of four modules from left to right: the TR-
LIFS subsystem, computer control unit, hybrid ultrasonic and spectro-
scopic probe, and UBM subsystem.
FIG. 2. Electronics and interfacing setup of the combined TR-LIFS/UBM
system. The schematic for the electronics configuration was designed to
ensure proper synchronization of various components and automation of the
data acquisition and analysis process. The interfaces dashed lines between
the control unit and subsystems integrated the TR-LIFS and UBM into one
functional system.
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The major specifications of the TR-LIFS system were
characterized, including the spectral and time resolution, sen-
sitivity, and data acquisition time. The spectral resolution of
the instrument was 5 nm as determined by the combination
of the linear dispersion of the grating, the entrance and exit
slit width. The time resolution of 300 ps was mainly de-
termined by the temporal response of the PMT, the preamp-
lifier, and the oscilloscope. This was further verified by mea-
suring the lifetime of Rose Bengal in methanol with
subnanosecond fluorescence lifetimes 0.58 ns. Estima-
tion of the intrinsic fluorescence decay was carried out via
deconvolution of the observed fluorescence traces from the
measured excitation pulse with the Laguerre deconvolution
approach.23 Experimentally, the measured excitation pulse
was obtained through direct recording of the reflected laser
light from samples using the same data acquisition settings,
which was the convolution of the excitation function with the
instrument response function. The average lifetime of the
fluorescence decay was computed as the interpolated time at
which the deconvolved fluorescence decayed to 1 /e of its
maximum value. The system’s sensitivity was determined to
be 10−9M of the Coumarin 1 solution in ethanol, emitting
fluorescence with the signal-to-noise ratio SNR value of
40, allowing the accurate estimation of lifetime. The data
acquisition time was 0.6 s per wavelength, including averag-
ing 12 decays at a laser repetition rate of 40 Hz, rotation of
the grating, and saving and transferring data.
The performance of the TR-LIFS instrument was vali-
dated by measuring the fluorescence emission of standard
dyes and biomolecules. The average lifetimes of typical stan-
dard dyes long, medium, and short lifetimes were found in
good agreement with the values reported in the literature
Table I.24–26 The data are reported as meanstandard error
of ten repeated measurements. Commercially available
samples of collagen type I from bovine Achilles tendon
C-9879, Sigma-Aldrich, St. Louis, MO and elastin from
human aorta E-6777, Sigma-Aldrich were tested in dry
powder form. Collagen type I and elastin have distinct emis-
sion spectra with an emission peak of 390 and 410 nm, re-
spectively Fig. 3a. They were clearly differentiated from
their fluorescence decay curves at 390 nm Fig. 3b, where
collagen had a long-lasting fluorescence emission when com-
pared to elastin.
B. UBM components
The electronics and interface diagram of the UBM
subsystem is also shown in Fig. 2. A high voltage pulser
AVB2-TE-C, Avtech Electrosystems, Ltd., Ottawa, Ontario,
Canada generating 1 cycle of a rectangular wave 200V
peak-to-peak with an adjustable period was used to drive the
transducer. The receiving circuit was constructed with a
commercial expander and limiter DEX-3 and DL-1, Matec
Instruments, Northborough, MA to protect the receiving cir-
cuitry from the high voltages required for transmission when
using the same transducer for transmitting and receiving. The
received RF echoes were amplified with a 30 dB low noise
amplifier Miteq 1114, Miteq Inc., Hauppauge, NY and fil-
tered with proper bandpass filters Mini-circuits, Brooklyn,
NY. A 12 bit analog-to-digital converter with a sampling
rate as high as 400 Msamples/s CompuScope 12400, GaGe
Applied Technologies, Lachine, QC, Canada was employed,
which maintained the SNR of the received RF signals and
provided good resolution and dynamic range of 60 dB. A
custom-built positioning assembly incorporating a miniature
precision linear motorized stage MX80L, 1 m resolution,
Parker-Daedal, Irwin, PA driven by a low noise servo drive
Vix250AH, Parker Hannifin, Rohnert Park, CA allowed for
scanning and forming an image. After digitization, signal
processing algorithms were applied to detect the echo en-
velop, logarithmically compress the RF data, and display the
B-mode images.
Various high frequency transducers with different speci-
fications 40–73 MHz could be used in this system. The
customized 45 MHz needle transducer aperture size of
0.4 mm0.4 mm, PMN-PT single crystal, Ultrasonic
Transducer Resource Center, University of Southern Califor-
nia, Los Angeles, CA used here had a 6 dB two-way frac-
tional bandwidth of 50%.27 The axial and lateral resolution
38 m and 200 m, respectively was estimated from the
image acquired by scanning across a 13 m tungsten wire
subresolution point target.
C. Combined probe and control unit of the integrated
system
A compact combined probe was constructed by assem-
bling either in parallel or concentrically the high frequency
ultrasonic transducer and the optical fiber Fig. 4. The com-
bined probe with the parallel assembly Figs. 4a and 4b
used an unfocused transducer with the piezoelectric material
of lithium niobate single crystal operating at around 60 MHz
and a 40 MHz focused ring transducer using lithium niobate
as the active element was placed in the concentric probe
Fig. 4c.28 The flexible design of the hybrid probe demon-
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FIG. 3. Time-resolved fluorescence measurements of elastin circle and
collagen type I triangle: a mean time-integrated spectra averaged over
ten measurements, and b mean deconvolved fluorescence decay traces ob-
tained at the wavelength of 390 nm.
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strated that an ample range of transducers with different
frequencies, aperture sizes, focusing, and materials and op-
tical fibers varied core sizes could be chosen for specific
purposes.
A computer, acting as the control unit, was used to inte-
grate the TR-LIFS and UBM components into one dual-
modal system using different types of interfaces including
local area network LAN and universal serial bus USB
Fig. 2. To increase the data acquisition speed, both the
commands and data transfer between the computer and TR-
LIFS subsystem were through LAN TCP/IP with a high
speed of 100 Mbytes/s, while the UBM data was digitized
locally by the acquisition board inside the computer. A spe-
cialized instrument control and user interface software inte-
grating the UBM and TR-LIFS was developed in LABVIEW
National instrument, Texas for system parameter adjust-
ments and various data acquisition tasks.
The control procedure for the dual-modal system was
accomplished through the software by scanning the sample
with the ultrasound transducer to form and display a B-mode
image, locating the region of interest, marking this point
digitally on the UBM images for subsequent correlation be-
tween the optical and the ultrasound data, and then guiding
the optical fiber to the proper location to perform TR-LIFS
measurements. Similar procedures were repeated until all the
regions of interest were examined by TR-LIFS along this
ultrasound scanning line.
III. SYSTEM VALIDATION
A. In vitro tissue phantom study
In order to validate the new hybrid spectroscopic and
ultrasonic system, as well as for coregistration of the ultra-
sonic image with spectroscopic data, a dual-modal tissue
phantom mimicking both the optical and acoustical proper-
ties of biological tissue was utilized. The tissue phantom is
briefly described and detailed elsewhere.29 The phantom con-
sisted of contrast agents including silicon dioxide particles
acting as both optical and acoustical scatterers, and fluores-
cein isothiocyanate FITC conjugated dextran mimicking
endogenous fluorophores in tissue. The agents were encap-
sulated in a polymer bead which was implanted into a gel
matrix with the desired pattern.
The phantom Fig. 5a contained 1 mm beads placed 6
mm apart and buried 2 mm below the surface of the gel
matrix. UBM images were first acquired to identify the dis-
tribution of the beads and compared with the real dimension
of the phantom to validate the ultrasonic data. In the UBM
image Fig. 5b, two beads 2 mm below the surface with a
measured distance between them of 6 mm appeared brighter
since the gel matrix was acoustically transparent, giving the
black background of the image. Due to the perpendicular
position of the transducer to the beads and the attenuation
caused by the ultrasonic scatterers inside the beads, only the
upper parts of the beads were shown in the image. The op-
tical fiber was then positioned by the host computer to the
region of interest, one of the beads, which was easily located
from the ultrasound image for TR-LIFS measurements. Since
the emission spectrum Fig. 5c acquired above the FITC
bead originated from the mixture of the bead and gel matrix,
two emission peaks at 410 nm fluorescence from the gel
matrix and 520 nm fluorescence mainly from FITC were
observed. From the deconvolved fluorescence decay at the
wavelength 520 nm Fig. 5d, the FITC lifetime of approxi-
mately 1.25 ns was found shorter than the lifetime of FITC
in solution. This discrepancy is mostly generated by the po-
lymerization process that trapped the FITC in a solid envi-
ronment, changing the lifetime of FITC as compared to pre-
viously reported values.30
B. Ex vivo human aorta atherosclerotic plaque study
To further demonstrate the feasibility of the hybrid sys-
tem for providing complementary diagnostic information
about atherosclerotic plaque morphology and biochemical
composition, ex vivo TRLIFS/UBM data were acquired from
ten human aorta samples postmortem specimens that dis-
played representative morphological and compositional fea-
tures. The specimens were visually inspected for features of
interest including thick intima, soft areas corresponding to
lipid pools, fibrotic areas, and calcification, photographed














FIG. 4. Color online a Picture of the hybrid TRLIFS/UBM probe encap-
sulating an ultrasound transducer and a single optical fiber with the parallel
assembly. b Microscope picture of the surface of the parallel combined
probe shown in a, demonstrating the 1 mm diameter transducer and
600 m fiber optics assembled in a 3.5 mm shaft tube. c Concentric
design of the hybrid probe combining a ring transducer and a single optical

































































Decay at 520 nm
Decay at 410 nm
FIG. 5. System validation and data coregistration using the dual-modal tis-
sue phantom. a Diagram of the phantom illustrating the distribution and
dimension of the FITC beads in the gel matrix. b Ultrasound B-mode
image 4 mm in depth and 10 mm in lateral direction showing two bright
beads inside the gel matrix. c Mean emission spectrum acquired from the
position above the FITC bead showing two emission peaks at 410 nm fluo-
rescence of the gel and 520 nm fluorescence of FITC. d Mean decon-
volved fluorescence decay traces based on the Laguerre basis expansion
technique obtained at the wavelength of 410 nm circle and 520 nm tri-
angle, where the averaged lifetimes were estimated to be 0.96 and 1.25 ns,
respectively.
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for investigation as follows. For each sample, a set of ultra-
sound B-mode images were constructed and visualized in
order to identify plaque points of interest for TR-LIFS data
collection. For each point, TR-LIFS data was acquired at the
emission wavelength range of 360–560 nm 5 nm interval.
After each TR-LIFS acquisition, the interrogated area was
marked with tissue ink for future correlation of the spectros-
copy results and ultrasound images with histopathology. Af-
ter the experiments, the marked tissue specimens were
placed in 10% formalin, sent for routine histopathological
analysis which included staining with hematoxylin and eosin
H and E and a combined trichrome/elastin method mature
collagen stained blue, elastin stained black, and smooth
muscle cells stained red in the trichrome/elastin stained sec-
tions.
Figure 6 summarizes the complementary information
provided by the two diagnostic approaches and the observed
correlation of the results against histopathology with
trichrome staining, the current diagnostic gold standard. Ac-
curate reconstruction of plaque morphology was displayed in
the ultrasonic image Fig. 6a, showing the delineation of
the layered structure and thickened intima and fibrous cap. In
spectroscopy Figs. 6c and 6d, fluorescence from the
normal position suggested the contribution of the elastin fi-
bers found in the media layer to the overall emission spec-
trum because the 337 nm laser pulse passed through the
80 m intima and reached the media layer consisting of
elastin the penetration depth of the UV light was approxi-
mately 250 m7. The trends of the fluorescence on the
plaque position demonstrated the large contribution to plaque
fluorescence emission of collagen within the thick fibrotic
cap of the intima 650 m. This was expected since the
excitation light cannot reach the media layer which is rich in
elastin. Overall, the spectroscopic results corresponded to the
fluorescence characteristics of collagen and elastin as previ-
ously reported24,31 and were validated by the corresponding
histopathology. In summary, UBM gave an accurate struc-
tural assessment of the vessel wall for defining the areas of
interest while spectroscopy data provided the chemical infor-
mation within the region. These findings demonstrated that
the two techniques were complementary to each other in the
characterization of the atherosclerotic plaque. In addition, ul-
trasound was a very sensitive method in vivo for the detec-
tion of calcium. Since the fluorescence spectroscopy at 337
nm excitation could not reliably discriminate calcium depos-
its, UBM was used as an alternative to identify such depos-
its. Calcified deposits were visualized by ultrasound as
“acoustic shadowing” since the calcified region reflected
most of the energy and obstructed the penetration of ultra-
sound. Figure 7 depicts an example of how ultrasound pro-
































































FIG. 6. Color Dual-modal measurements of the ex vivo human aorta ath-
erosclerotic plaque samples showing the complementary information pro-
vided by TR-LIFS and UBM. a UBM image demonstrated the fibrous cap
L adjacent to the muscular media, compared to the thin layer of normal
intima R. b Trichrome/elastin stained section mature collagen stained
blue, elastin stained black, and smooth muscle cells stained red showed the
650 m fibrous cap L and the normal intima layer with the thickness of
80 m R. c and d Fluorescence measurements were taken at normal
and plaque position marked on the histology and ultrasound image arrows.
Fluorescence at normal position circle showed broad average emission
spectrum c and relatively short-lasting decay as reflected by the average
lifetime d. Fluorescence at plaque position triangle showed narrower
spectra c, relatively long-lasting emission as reflected by the lifetime at



































































FIG. 7. Color Dual-modal measurements of the ex vivo human atheroscle-
rotic plaque with calcified lesion, showing how ultrasound provided diag-
nostic information on calcified plaques and improved the TR-LIFS detec-
tion. a UBM image showing the bright region with acoustic shadowing
below M which was the calcified lesion. b Trichrome/elastin stained
section mature collagen stained blue, elastin stained black and smooth
muscle cells stained red. A 240 m fibrous cap, below which was a lipid
pool with calcification M and the 160 m intima thickening R were
observed. c Comparison of the average fluorescence emission spectrum
between the plaque mainly from the fibrous cap above the calcified lesion
and intima thickening. d Comparison of the average lifetime as a function
of wavelength between the plaque and intima thickening.
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complementing the TR-LIFS detection. The calcified deposit
was detected by ultrasound Fig. 7a and verified by histo-
pathology Fig. 7b. Since 337 nm laser excitation could
barely penetrate the 240 m fibrous cap above the calcium
deposit, fluorescence spectrum and lifetime Figs. 7c and
7d showed similar characteristics as the fluorescence mea-
surements of the fibrous cap in Fig. 6. Even if the UV light
can reach the calcium deposits, no fluorescence emission is
expected from calcium upon 337 nm excitation. Therefore,
the ultrasonic images can be used to identify the area with
calcified lesion, thus providing complementary information
for the TR-LIFS method.
IV. DISCUSSION
A. Unique features of the dual-modal system
A unique feature of the two-modal technology was that
UBM relatively high penetration depth 6 mm at 45 MHz
allows for the examination of plaque structure within its en-
tire cross section when compared to TR-LIFS which allows
for evaluation of the composition of the fibrotic cap within
only a few hundred micrometers. This is important because
complementary diagnostic information concerning the tissue
in question is obtained. For example, UBM enabled high
resolution imaging 40 m at 45 MHz of the anatomy of
the plaques and provided both diagnostic information size
and location of the lipid or necrotic core, thickness of the
fibrotic cap, presence of calcium deposits and guidance for
the TR-LIFS measurements to areas of interest––such
as those characterized by a thin fibrotic cap with a large
lipid pool. Further investigation of such areas by
TR-LIFS allows for identification of the actual composition
of the thick fibrotic cap collagen versus lipid/macrophage
content which plays an important role in plaque instability
and rupture. A thick fibrotic cap with high collagen content is
known as being more stable while one rich in lipid-laden
macrophages is more likely to become unstable and to rup-
ture.
B. Pathways to clinical applications
Because our goal is to use this hybrid technology for
intravascular investigations, emphasis is placed on identify-
ing approaches that lead to a the development of a compact
intravascular catheter which incorporates TR-LIFS and UBM
IVUS, b high-resolution UBM systems for accurate dis-
crimination of distinct morphological features in plaques,
and c fast TR-LIFS data acquisition for near real time tis-
sue diagnosis. Our group has already addressed the latter
aspect by developing a simultaneous time- and wavelength-
resolved fluorescence spectroscopy technique. This tech-
nique, recently reported by our group,32 provides the oppor-
tunity for real-time tissue characterization or diagnosis. It
enables the reduction of the data acquisition time from the
current 20 s for a TR-LIFS scan 200 nm, every 5 nm to
hundreds of nanoseconds for acquisition of the time-resolved
data in multiple and specific spectral bands for tissue diag-
nosis. In addition, the flexibility of the design of the hybrid
probe described here has allowed for the selection of a wide
variety of transducers. This includes both unfocused and fo-
cused transducers with different f numbers and frequencies,
parameters which in turn define the spatial resolution of the
UBM subsystem. Transducers with high frequencies above
50 MHz are expected to provide improved spatial resolution
and image quality and are suitable for applications requiring
a penetration depth of several millimeters. For example, the
70 MHz transducer tested in this study can approach ultimate
lateral resolution of approximately 60 m for an f number
of 2, and axial resolution typically of 15 m. Moreover,
current research in our group33 focuses on translating the
rigid probe used in this study into a flexible hybrid catheter
which integrates a side-viewing single fiber optic probe for
TR-LIFS with a high frequency IVUS catheter. This will
enable future evaluation of the dual-modal system for intra-
vascular applications.
V. CONCLUSION
We developed a dual-modal tissue diagnosis system
combining time-resolved laser-induced fluorescence spec-
troscopy and high frequency ultrasound imaging. The system
was calibrated and validated both in vitro and ex vivo situa-
tions. The preliminary data presented in the results section
demonstrated a number of noteworthy findings. First, ex vivo
spatially correlated ultrasonic and TR-LIFS studies were fea-
sible with available probes. Second, the close similarity be-
tween the tissue morphology shown by ultrasound and the
corresponding histopathology demonstrated that ultrasound
could be used as a guidance tool to indicate possible unstable
plaque areas for subsequent fluorescence studies. Finally,
compositional information such as calcified region, specifi-
cally detected by ultrasound, demonstrated that ultrasound
could provide complementary information regarding plaque
composition. The system showed great potentials as an opti-
mal approach for the detection of rupture-prone plaques that
incorporated structural definition provided by the high-
resolution ultrasound with the biochemical processes de-
tected by fluorescence spectroscopy. Ultrasound imaging
may serve as both a guiding tool for the use of TR-LIFS and
a complementary tool for diagnosing features of plaque vul-
nerability. Future catheter-based intravascular hybrid system
can be used for the identification of patients who are more
likely to have a vulnerable plaque and can be used to study
dynamically the effects of therapy.
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